United Microelectronics: "This is exactly the sweet spot. We need these kinds of integrated circuits, that's in short supply. ... I like your idea. There is a shortage and they are a part of the answer, not the problem."
Enterprise Products Partners: "EPD's probably the best one. I stopped recommending these because I really feel like that they've hurt so many people, but if you want one ... then Enterprise Product Partners with a 7% yield is probably the best."
Magellan Midstream Partners: "I have cooled on this group."
GlaxoSmithKline: "Glaxo has been a big disappointment. ... I have just been wrong and I'm struggling, but I would say do not sell it with a 7% yield down here, but I have been wrong and I have to own that."
Palantir: "Palantir's become the most controversial stock in this market ... a very good fund, ARK, keeps buying the stock ... but it's become such a battleground that I have to say next."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com